ASH 2018: Best Kept Secret at ASH in Multiple Myeloma
Identifying and Killing Myeloma Cells That Cause Myeloma and Relapse with MCRI Award Winner Dr. Frank Zhan and Dr. Yogesh Jethava
If patients were able to receive full myeloma therapy including therapy that could kill initiating cells, we would be much closer to a cure.
Clinical Trial: The MyDrug MMRF Study Recruiting for 228 Myeloma Patients
Day 1 of Myeloma Giving: I Don't Have Melanoma, I Have Multiple Myeloma
ASH 2018: Adding Daratumumab to Velcade/Revlimid/Dex Effective for Newly Diagnosed Multiple Myeloma
ASH 2018: Ixazomib and Elotuzumab Combos are Promising for High-Risk Smoldering Patients
ASH 2018: Poster Sessions at ASH Can Share Some Great Information!
A Tribute to Multiple Myeloma Advocate Eric Hansen
ASH 2018: Ninlaro as a Maintenance Therapy After Transplant
ASH 2018: Early Relapse After Transplant - A New Indicator of Outcomes for Myeloma Patients?
Dr. Parameswaran Hari of the Medical College Of Wisconsin Selects His top 6 ASH 2018 Abstracts
ASH 2018: High Risk and "Double Hit" Myeloma
ASH 2018: MRD Testing and Myeloma Treatment Choices by Dr. Ola Landgren
Dr. Ola Landgren Of MSKCC Selects His Top 5 ASH 2018 Myeloma Abstracts
Fortis Therapeutics Opens New Antibody Phase I Study in Multiple Myeloma Targeting CD46
What is the American Society of Hematology (ASH) Meeting and Why Does It Matter for Myeloma Patients?
Sparking a Cure for Multiple Myeloma: Brian McMahon, Founder of SparkCures
The Leukemia & Lymphoma Society Shows Support of Clinical Treatment Act
Creating an Immune System Signature to Gauge Myeloma Risk with MCRI Award Winner David Chung, MD, MSKCC
Learn why studying the immune system may be just as important as the study of myeloma genetics and what this research can mean for you personally.
Thalidomide Included in Induction and Maintenance Increases Survival in European Study
The Right to Try Act and What It Means for Myeloma Patients
Flu Season: Preparing and Protecting the Immune System When You Have Multiple Myeloma
Buffalo Round Table - November 10, 2018
Antibody Drug Conjugates As Immunotherapy In Myeloma
